The ROE as of December 2024 (TTM) for Guardion Health Sciences, Inc. (GHSI) is 77.24%

According to Guardion Health Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 77.24%. This represents a change of -673.26% compared to the average of -13.47% of the last 4 quarters.

Guardion Health Sciences, Inc. (GHSI) Historical ROE (quarterly & annually)

How has GHSI ROE performed in the past?

The mean historical ROE of Guardion Health Sciences, Inc. over the last ten years is 160.32%. The current 77.24% ROE has changed -51.82% with respect to the historical average. Over the past ten years (40 quarters), GHSI's ROE was at its highest in in the December 2016 quarter at 667.74%. The ROE was at its lowest in in the December 2022 quarter at -184.14%.

Guardion Health Sciences, Inc. (GHSI) ROE by Quarter and Year

Discovering the peaks and valleys of Guardion Health Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Guardion Health Sciences, Inc. (GHSI) Average ROE

How has GHSI ROE performed in the past?

The current ROE of Guardion Health Sciences, Inc. (GHSI) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Guardion Health Sciences, Inc. (GHSI) ROE vs. Peers

How is GHSI’s ROE compared to its peers?

Guardion Health Sciences, Inc.’s ROE is greater than Biofrontera Inc. (-324.62%), greater than Shuttle Pharmaceuticals Holdings, Inc. (-582.98%), greater than Akanda Corp. (-753.35%), greater than China Pharma Holdings, Inc. (-63.93%), less than Agile Therapeutics, Inc. (104.04%), greater than Alpha Teknova, Inc. (-37.32%), less than Cyclo Therapeutics, Inc. (749.85%), greater than Petros Pharmaceuticals, Inc. (-122.55%), less than Lifecore Biomedical, Inc. (17.23%), greater than Organogenesis Holdings Inc. (-2.69%), less than Aquestive Therapeutics, Inc. (62.93%), greater than Evoke Pharma, Inc. (-308.51%), greater than Adamis Pharmaceuticals Corporation (0.33%), greater than AcelRx Pharmaceuticals, Inc. (-118.55%), greater than Universe Pharmaceuticals INC (-55.97%), greater than Qilian International Holding Group Limited (-16.24%), greater than IM Cannabis Corp. (-139.03%), less than GelStat Corporation (0%), less than null (28.58%),

Build a custom stock screener for Guardion Health Sciences, Inc. (GHSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guardion Health Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Guardion Health Sciences, Inc. (GHSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Guardion Health Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.